A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Associate Director - Regulatory Affairs, CMC-Biologics

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-time$170.9k - $231.3k

About the Job

Requirements

  • An advanced degree in chemistry, biochemistry, pharmaceutical sciences, molecular biology, or a related discipline.
  • Demonstrated experience supporting therapeutic products through multiple stages of development.
  • A minimum of 8–10 years of industry experience in the pharmaceutical or biotechnology industry, including at least 5 years of Regulatory Affairs CMC experience.
  • Ability to interpret complex technical, nonclinical, clinical, and manufacturing information and translate it into clear regulatory strategies.
  • Experience with regulatory submissions and health authority interactions for development-stage programs.
  • Ability to evaluate emerging technologies and apply sound regulatory judgment in a fast-paced, evolving environment.
  • Ability to integrate scientific, technical, and regulatory considerations into clear actionable strategies.

Responsibilities

  • Lead the development and execution of global CMC regulatory strategies for innovative small molecules, biologics, and complex modalities across early- and late-stage development.
  • Plan, review, and prepare CMC documentation for clinical trial applications, marketing authorization applications, and health authority briefing packages.
  • Lead or help lead the interpretation of regulatory expectations for emerging modalities, including oligonucleotide therapeutics, conjugated delivery systems such as GalNAc and other targeting ligands, antibody-drug conjugates, peptide conjugates, and biologic or hybrid modalities.
  • Serve as a strategic interface between Research, Pharmaceutical Development, Technical Operations, and Regulatory Sciences.
  • Provide strategic guidance on product characterization, control strategies, comparability approaches, and regulatory classification considerations.
  • Represent Regulatory Affairs CMC in cross-functional governance, development, and portfolio discussions.
  • Partner with technical teams to identify regulatory risks and develop proactive mitigation strategies.
  • Contribute to regulatory intelligence activities and interpretation of evolving policy for novel modalities.
  • Help build Regulatory Affairs CMC infrastructure, processes, and organizational capability.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs